Access cutting-edge hepatocellular carcinoma treatment through this clinical trial at a research site in New Brunswick. Study-provided care at no cost to qualified participants.
Access hepatocellular carcinoma specialists in New Brunswick at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hepatocellular carcinoma treatment provided free
The investigators hypothesize that the addition of Tislelizumab after definitive local therapy for locally advanced inoperable Hepatocellular carcinoma (HCC) will synergize with local therapy as well as treat micro metastatic disease and improve one year progression-free survival rates for participants and optimize local control.
Sponsor: Rutgers, The State University of New Jersey
Check if you qualify for this hepatocellular carcinoma clinical trial in New Brunswick, NJ
If you're searching for hepatocellular carcinoma treatment options in New Brunswick, NJ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Brunswick research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hepatocellular carcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.